NuCana (NCNA) Change in Cash (2017 - 2025)
NuCana (NCNA) reported Change in Cash of -$1.3 million for Q4 2025, up 80.07% on a YoY basis from -$745323.1 in Q4 2024, and down 106.0% sequentially from $22.4 million in Q3 2025.
NuCana (NCNA) Change in Cash (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Change in Cash data on file, last reported at -$1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash rose 80.07% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at $14.4 million (up 204.15% YoY), and the FY2025 full-year result was $23.3 million, up 268.17% from the prior year.
- Change in Cash fell to -$1.3 million in Q4 2025, from $22.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $22.4 million in Q3 2025 to a low of -$14.3 million in Q4 2021.
- A 5-year average of -$5.0 million and a median of -$6.9 million in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash plunged 8000.1% in 2024 and surged 18821.79% in 2025, its largest moves.
- Tracing NCNA's Change in Cash over 5 years: stood at -$14.3 million in 2021, then soared by 45.97% to -$7.7 million in 2022, then jumped by 98.93% to -$83157.2 in 2023, then sank by 8000.1% to -$6.7 million in 2024, then jumped by 80.07% to -$1.3 million in 2025.
- Business Quant data shows NCNA's Change in Cash at -$1.3 million in Q4 2025, $22.4 million in Q3 2025, and -$6.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 53.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 22.37 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | 118,236.32 |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Dec 31, 2023 | -83,157.18 |
| Sep 30, 2023 | -9.45 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -12.41 Mn |
| Dec 31, 2022 | -7.74 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | -11.47 Mn |
| Mar 31, 2022 | -11.85 Mn |
| Dec 31, 2021 | -14.32 Mn |
| Sep 30, 2021 | -5.07 Mn |
| Jun 30, 2021 | -7.14 Mn |
| Mar 31, 2021 | -11.13 Mn |
| Dec 31, 2020 | -12.20 Mn |
| Sep 30, 2020 | 70.33 Mn |